Aortic valve disease and gamma-glutamyltransferase: Accumulation in tissue and relationships with calcific degeneration

Atherosclerosis

Volumn 213, Issue 2, 2010, Pages 385-391

  Cappelli, Stefania ^a   Epistolato, Maria Carmela ^a   Vianello, Annamaria ^b   Mazzone, Annamaria ^b   Glauber, Mattia ^b   Franzini, Maria ^c   Ottaviano, Vittoria ^d   Pompella, Alfonso ^d   Paolicchi, Aldo ^d   Tanganelli, Piero ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b CNR   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Aortic valve stenosis; Calcification; Gamma glutamyltransferase; Lipoprotein; Osteoclast like cells

Indexed keywords

CHLORDANE; GAMMA GLUTAMYLTRANSFERASE; GELATINASE B; HIGH DENSITY LIPOPROTEIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TRIACYLGLYCEROL;

AGED; AORTA VALVE DISEASE; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ATHEROSCLEROSIS; BIOACCUMULATION; BLOOD VESSEL CALCIFICATION; CALCIUM METABOLISM; DEGENERATIVE DISEASE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEART VENTRICLE PRESSURE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MULTINUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CALCINOSIS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9;

EID: 78649740514     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.08.063     Document Type: Article

References (43)

1. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006, 114:84-231.
2. O'Brien K.D. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 2006, 26:1721-1728.
3. Otto C.M., Kuusisto J., Reichenbach D.D., Gown A.M., O'Brien K.D. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994, 90:844-853.
4. Mazzone A., Epistolato M.C., Gianetti J., et al. Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease?. Am J Clin Pathol 2006, 126:494-502.
5. Rajamannan N.M., Subramaniam M., Rickard D., et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003, 107:2181-2184.
6. Li Y.B., Hu C.L., Liu J., Tang Q.Z., Huang C.X. Calcific aortic valve disease should not be considered as a degenerative disease anymore. Med Hypotheses 2007, 68:1233-1235.
7. Helske S., Kupari M., Lindstedt K.A., Kovanen P.T. Aortic valve stenosis: an active other inflammatory process. Curr Opin Lipidol 2007, 18:483-491.
8. Bossé Y., Mathieu P., Pibarot P. Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis. J Am Coll Cardiol 2008, 51:1327-1336.
9. Kaden J.J., Dempfle C.E., Grobholz R., et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005, 14:80-87.
10. Durbin A.D., Gotlieb A.I. Advances towards understanding heart valve response to injury. Cardiovasc Pathol 2002, 11:69-77.
11. Liberman M., Bassi E., Martinatti M.K., et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol 2008, 28:463-470.
12. Lee D.S., Evans J.C., Robins S.J., et al. Glutamyl transferase and metabolic syndrome, cardiovascular disease and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007, 27:127-133.
13. Franzini M., Corti A., Martinelli B., et al. γ-Glutamyltransferase activity in human carotid atherosclerotic plaques-biochemical similarities with the circulating enzyme. Atherosclerosis 2008, 202:119-127.
14. Paolicchi A., Emdin M., Passino C., et al. Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 2006, 186:80-85.
15. Emdin M., Pompella A., Paolicchi A. Gamma-glutamyltransferase, atherosclerosis and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005, 112:2078-2080.
16. Niida S., Kawahara M., Ishizuka Y., et al. Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor. J Biol Chem 2004, 279:5752-5756.
17. Hiramatsu K., Asaba Y., Takeshita S., et al. Overexpression of gamma-glutamyltransferase in transgenic mice accelerated bone resorption and causes osteoporosis. Endocrinology 2007, 148:2708-2715.
18. Franzini M., Bramanti E., Ottaviano V., et al. A high performance gel filtration chromatography method for gamma-glutamyltransferase fraction analysis. Anal Biochem 2009, 374:1-6.
19. Franzini M., Ottaviano V., Fierabracci V., et al. Fractions of plasma gamma-glutamyltransferase in healthy individuals: reference values. Clin Chim Acta 2008, 395:188-189.
20. Mazzone A., Epistolato M.C., De Caterina R., et al. Neoangiogenesis, T-lymphocyte infiltration and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis. J Am Coll Cardiol 2004, 43:1670-1676.
21. Edwards A.M. Regulation of gamma-glutamyltranspeptidase in rat hepatocyte monolayer cultures. Cancer Res 1982, 42:1107-1115.
22. Rajamannan N.M., Subramaniam M., Stock S.R., et al. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 2005, 91:806-810.
23. Charest A., Pepin A., Shetty R., et al. Distribution of SPARC during neovascularization of degenerative aortic stenosis. Heart 2006, 92:1844-1849.
24. Mohler E.R., Gannon F., Reynolds C., Zimmerman R., Keane M.G., Kaplan F.S. Bone formation and inflammation in cardiac valves. Circulation 2001, 103:1522-1528.
25. Mohler E.R. Mechanisms of aortic valve calcification. Am J Cardiol 2004, 94:1396-1402.
26. Goldbarg S.H., Elmariah S., Miller M.A., Fuster V. Insights into degenerative aortic valve disease. J Am Coll Cardiol 2007, 50:1205-1213.
27. Kazemi-Shirazi L., Endler G., Winkler S., Schickbauer T., Wagner O., Marsik C. Gamma glutamyltransferase and long-term survival: is it just the liver?. Clin Chem 2007, 53:940-946.
28. Jacob M.P. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 2003, 57:195-202.
29. Mason D.P., Kenagy R.D., Hasenstab D., et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res 1999, 85:1179-1185.
30. Sundaram K., Nishimura R., Senn J., Youssef R.F., London S.D., Reddy S.V. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res 2007, 313:168-178.
31. Massy Z.A., Mentaverri R., Mozar A., Brazier M., Kamel S. The pathophysiology of vascular calcification: are osteoclast-like cells the missing link?. Diabetes Metab 2008, 34(Suppl. 1):S16-S20.
32. Hanigan M.H. Gamma-glutamyl transpeptidase, a glutathionase: its expression and function in carcinogenesis. Chem Biol Interact 1998, 111-112:333-342.
33. Stark A.A., Zeiger E., Pagano D.A. Glutathione mutagenesis in Salmonella typhimurium is a gamma glutamyltranspeptidase-enhanced process involving active oxygen species. Carcinogenesis 1988, 9:771-777.
34. Mody N., Parhami F., Sarafian T.A., Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med 2001, 31:509-519.
35. Steitz S.A., Speer M.Y., Curinga G., et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and down-regulation of smooth muscle lineage markers. Circ Res 2001, 89:1147-1154.
36. Tintut Y., Alfonso Z., Saini T., et al. Multilineage potential of cells from the artery wall. Circulation 2003, 108:2505-2510.
37. Johnson R.C., Leopold J.A., Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006, 99:1044-1059.
38. Steinbeck M.J., Appel W.H., Verhoeven A.J., Karnovsky M.J. NADPH-oxidase expression and in situ production of superoxide by osteoclasts actively resorbing bone. J Cell Biol 1994, 126:765-772.
39. Khalaf M.R., Hayhoe F.G.J. Cytochemistry of gamma-glutamyltrans-ferase in haemic cells and malignancies. Histochem J 1987, 19:385-395.
40. Franzini M., Corti A., Fornaciari I., et al. Cultured human cells release soluble gamma-glutamyltransferase complexes corresponding to the plasma b-GGT. Biomarkers 2009, 7:486-492.
41. Ruttmann E., Brant L.J., Concin H., Diem G., Rapp K., Ulmer H. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality. An investigation in a cohort of 163,944 Austrian adults. Circulation 2005, 112:2130-2137.
42. Lee D.H., Silventoinen K., Hu G., et al. Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28,838 middle-aged men and women. Eur Heart J 2006, 27:2170-2176.
43. Franzini M., Paolicchi A., Fornaciari I., et al. Cardiovascular risk factors and gamma-glutamyltransferase fractions in healthy individuals. Clin Chem Lab Med 2010, 48:713-717.